116 related articles for article (PubMed ID: 303493)
21. Detection of circulating immune complexes with polyethylene glycol precipitation F(ab')2 anti-C3 ELISA.
Xu RJ; Gu YA
J Immunol Methods; 1990 Dec; 135(1-2):225-31. PubMed ID: 2273258
[TBL] [Abstract][Full Text] [Related]
22. Detection of circulating immune complexes in liver diseases, systemic lupus erythematosus and glomerulonephritis by polyethylene glycol precipitation.
Shou L; Yang HM; Chang CM; Good RA
Proc Natl Sci Counc Repub China B; 1986 Jul; 10(3):167-74. PubMed ID: 3774914
[TBL] [Abstract][Full Text] [Related]
23. Characterization of DNA in polyethylene glycol precipitated immune complexes from sera of patients with systemic lupus erythematosus.
Ikebe K; Gupta RC; Tan EM
Clin Exp Immunol; 1983 Oct; 54(1):169-77. PubMed ID: 6616966
[TBL] [Abstract][Full Text] [Related]
24. Autoantibodies associated with RNA are more enriched than anti-dsDNA antibodies in circulating immune complexes in SLE.
Ahlin E; Mathsson L; Eloranta ML; Jonsdottir T; Gunnarsson I; Rönnblom L; Rönnelid J
Lupus; 2012 May; 21(6):586-95. PubMed ID: 22300829
[TBL] [Abstract][Full Text] [Related]
25. Comparison of anti 60 and 52 kDa SS-A/Ro antibodies in the pathogenesis of cutaneous lupus erythematosus.
Yoshimasu T; Hiroi A; Ohtani T; Uede K; Furukawa F
J Dermatol Sci; 2002 May; 29(1):35-41. PubMed ID: 12007719
[TBL] [Abstract][Full Text] [Related]
26. Reduced complement-mediated immune complex solubilizing capacity and the presence of incompletely solubilized immune complexes in SLE sera.
Baatrup G; Petersen I; Jensenius JC; Svehag SE
Clin Exp Immunol; 1983 Nov; 54(2):439-47. PubMed ID: 6652967
[TBL] [Abstract][Full Text] [Related]
27. Detection of circulating immune complexes by PEG precipitation combined with ELISA.
Ohlson S; Zetterstrand K
J Immunol Methods; 1985 Feb; 77(1):87-93. PubMed ID: 3973400
[TBL] [Abstract][Full Text] [Related]
28. [Relationship of renal histopathology to immunoglobulin classes and complement fixation of anti-native DNA antibodies and components of immune complexes in patients with systemic lupus erythematosus (author's transl)].
Hashimoto H; Utagawa Y; Yamagata J; Okada T; Shiokawa Y; Suzuki S; Tomiyama T
Ryumachi; 1981 Sep; 21(5):366-74. PubMed ID: 6977194
[No Abstract] [Full Text] [Related]
29. Relationship between anti-DNA antibodies complement consumption and circulating immune complexes in systemic lupus erythematosus.
Davis P; Cumming RH; Verrier-Jones J
Clin Exp Immunol; 1977 May; 28(2):226-32. PubMed ID: 301447
[TBL] [Abstract][Full Text] [Related]
30. The atherogenic effect of lupus sera: systemic lupus erythematosus-derived immune complexes stimulate the accumulation of cholesterol in cultured smooth muscle cells from human aorta.
Kabakov AE; Tertov VV; Saenko VA; Poverenny AM; Orekhov AN
Clin Immunol Immunopathol; 1992 Jun; 63(3):214-20. PubMed ID: 1623641
[TBL] [Abstract][Full Text] [Related]
31. Detection and characterization of DNA-anti-DNA complexes in a patient with systemic lupus erythematosus.
Bruneau CD; Edmonds JP; Hughes GR; Aarden L
Clin Exp Immunol; 1977 Jun; 28(3):433-6. PubMed ID: 302166
[TBL] [Abstract][Full Text] [Related]
32. Fc-rosette inhibition by hypocomplementaemic systemic lupus erythematosus sera.
Morito T; Tanimoto K; Hashimoto Y; Horiuchi Y; Juji T
Ann Rheum Dis; 1975 Oct; 35(5):415-21. PubMed ID: 1086653
[TBL] [Abstract][Full Text] [Related]
33. IgG subclasses of PEG precipitable IgG in systemic lupus erythematosus sera.
Morland C; Michael J; Adu D
Clin Nephrol; 1989 Apr; 31(4):204-9. PubMed ID: 2714025
[TBL] [Abstract][Full Text] [Related]
34. Serum levels of the regulatory cytokines transforming growth factor-β and interleukin-10 are reduced in patients with discoid lupus erythematosus.
Antiga E; Del Bianco E; Difonzo E; Fabbri P; Caproni M
Lupus; 2011 May; 20(6):556-60. PubMed ID: 21372199
[TBL] [Abstract][Full Text] [Related]
35. Detection of circulating immune complexes in human sera by simplified assays with polyethylene glycol.
Digeon M; Laver M; Riza J; Bach JF
J Immunol Methods; 1977; 16(2):165-83. PubMed ID: 881555
[TBL] [Abstract][Full Text] [Related]
36. Complement fixing immune complexes containing antinuclear antibodies in patients with systemic lupus erythematosus.
Budd JJ; Moore TL; Osborn TG
J Rheumatol; 1988 Feb; 15(2):247-50. PubMed ID: 3258914
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of different methods for detecting circulating immune complexes. An inter-laboratory study.
Füst G; Kavai M; Szegedi G; Meretey K; Falus A; Lenkey A; Misz M
J Immunol Methods; 1980; 38(3-4):281-9. PubMed ID: 7440977
[TBL] [Abstract][Full Text] [Related]
38. Prognostic implications of active discoid lupus erythematosus and malar rash at the time of diagnosis of systemic lupus erythematosus: Results from a prospective cohort study.
Drucker AM; Su J; Mussani F; Siddha SK; Gladman DD; Urowitz MB
Lupus; 2016 Apr; 25(4):376-81. PubMed ID: 26453664
[TBL] [Abstract][Full Text] [Related]
39. The presence of anti-basement membrane zone antibodies in the sera of patients with non-bullous lupus erythematosus.
Ishikawa O; Zaw KK; Miyachi Y; Hashimoto T; Tanaka T
Br J Dermatol; 1997 Feb; 136(2):222-6. PubMed ID: 9068736
[TBL] [Abstract][Full Text] [Related]
40. [Detection of circulating antigen-antibody complexes by precipitation with C1q and polyethylene glycol].
Nydegger U; Gerber H; Lambert PH; Miescher PA
Schweiz Med Wochenschr; 1974 Jan; 104(4):126-7. PubMed ID: 4544103
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
